logo
logo
  • What we do
    • Strategic and Tactical Competitive Insights
    • Digital Health, Artificial Intelligence & Internet of Everything
    • Gene & Cell Therapy and Rare Diseases’ Research
    • Vaccines & Infectious Diseases Research
    • Investment Insights
  • News
  • Insights
  • Our work
  • LucidSearch
  • QuickAnswers
  • Contact Us
  • Search

competitive intelligence

LucidQuest Our Work Competitive Intelligence

How we contributed to our client's marketing strategy so that they succeed in the ever-evolving Atopic Dermatitis landscape.

The challenge: Being in the loop in the Atopic Dermatitis landscape A Top-10…


by LucidQuest

LucidQuest Cell and Gene Therapy Case Study

How a leading Biotech company supported its go-/no-go decision in the ophthalmology gene therapy (GT) space through a workshop.

The Challenge: Uncovering perceptions of GT in ophthalmology. LucidQuest…


by LucidQuest

LucidQuest Cell and Gene Therapy Case Study

How we helped a Top-10 BioPharma company enhance its strategic decision-making in the Sickle Cell Disease space.

The challenge: To map the competitive landscape in Cell and Gene Therapy for…


by LucidQuest

LucidQuest Cell and Gene Therapy Case Study

How LucidQuest insights helped a global leader in the Hemophilia space with its branding and positioning strategy.

The Challenge: To track the novel treatments’ (including gene and RNA…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

How our strategic intelligence helped a respiratory brand, understand the future landscape and adapt its clinical development program (CDP).

The Challenge: Staying updated with the ever-changing competitive landscape in…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

How we allayed a major pharma΄s concerns about Gx entrants and supported unbiased decision-making in the EU market. 

The challenge: Estimating the threat of existing and potential generic…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

How we helped a mid-size Pharma delve into the competitor landscape and support its brand strategy development.

The challenge: Βuilding an up-to-date biosimilar competitor landscape.  A…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

How we helped a mid-size pharma prepare its sales (SF) and medical teams (MSL) for a competitor's new launch in the migraine prevention space.

The Challenge: Knowing your competitor's new asset market entry timelines.…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

A major pharma in the COPD / Asthma space strengthened its market position due to competitive intelligence obtained through conference coverage.

The Challenge: Gathering competitive intelligence at conferences Α major…


by LucidQuest

LucidQuest Case Study Oncology

How a large pharma in the EU oncology space gained and used competitive intelligence to craft a defense against threats from generics.

The Challenge: Gaining Competitive Intelligence on upcoming generics…


by LucidQuest

LucidQuest Case Study Hematology

How our benchmarking analysis contributed to a Hemato-Oncology company's sales and pricing strategy for specific agents.

The Challenge: Competitive benchmarking, including sales force and market…


by LucidQuest

LucidQuest Case Study Hematology

How a hematology brand utilized competitor sales force research to defend itself against a competitor entrant in Spain.

The Challenge: How to react to a new entrant threat A hematology brand team of…


by LucidQuest

Categories

  • Insights
  • Case studies
  • News

Recent Posts

  • Public Health Weekly News – June 13th 2025
  • Respiratory Weekly News – June 13th 2025
  • Vaccines Weekly Update – June 13th 2025
  • Cell and Gene Therapy Weekly News – June 12th 2025
  • Rare Diseases Weekly News – June 12th 2025

Tags

ABRYSVO advanced therapies AI in Medical Affairs antibiotics antimicrobial resistance bioinformatics biosimilar drugs cancer casestudy co-pilot complex innovative design corporate venture capital Diabetes management dostarlimab early stage Elranatamab ESMO 2021 Galderma gene editing gene therapy approval Healthcare Innovation Healthcare marketing hematology hpv HPV Vaccine interchangeability IoT lung cancer medical education mRNA technology NFTs in healthcare non viral vectors pharma Pricing Strategy pulmonary care rare disease recombinant Recursion Pharmaceuticals Routine Immunization Sales Strategy Sema4 SUBQ T2D vaccine distribution οur work

Archives

  • 1
  • 2
  • 3
LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

  • Public Health Weekly News – June 13th 2025
  • Respiratory Weekly News – June 13th 2025
  • Vaccines Weekly Update – June 13th 2025
  • Cell and Gene Therapy Weekly News – June 12th 2025
  • Rare Diseases Weekly News – June 12th 2025

TAGS

ABRYSVO advanced therapies AI in Medical Affairs antibiotics antimicrobial resistance bioinformatics biosimilar drugs cancer casestudy co-pilot complex innovative design corporate venture capital Diabetes management dostarlimab early stage Elranatamab ESMO 2021 Galderma gene editing gene therapy approval Healthcare Innovation Healthcare marketing hematology hpv HPV Vaccine interchangeability IoT lung cancer medical education mRNA technology NFTs in healthcare non viral vectors pharma Pricing Strategy pulmonary care rare disease recombinant Recursion Pharmaceuticals Routine Immunization Sales Strategy Sema4 SUBQ T2D vaccine distribution οur work
  • What we do
    • Strategic and Tactical Competitive Insights
    • Digital Health, Artificial Intelligence & Internet of Everything
    • Gene & Cell Therapy and Rare Diseases’ Research
    • Vaccines & Infectious Diseases Research
    • Investment Insights
  • News
  • Insights
  • Our work
  • LucidSearch
  • QuickAnswers
© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.
Privacy Policy